by recall bias. Moreover, the disease process has a preclinical phase characterized by the presence of autoimmunity to islet antigens, and little is known about the influence of environment on this early induction of islet autoimmunity. BABY-DIAB is a prospective study from birth in offspring of parents with type 1 diabetes that evaluates the appearance of islet antibodies in relation to environmental factors and genetic markers (6) (7) (8) (9) . To determine whether environmental factors may influence the appearance of autoimmunity, we have analyzed in a prospective manner the relationship between breast-feeding duration, vaccinations, and viral infections and the development of islet autoimmunity and progression to clinical disease in BABYDIAB offspring.
RESEARCH DESIGN AND METHODS

Study population
The German BABYDIAB Study is a prospective evaluation of risk and protective factors for the development of type 1 diabetes in offspring of parents with type 1 diabetes. The study is described in detail by Ziegler et al. (6) . By design, visits for venous blood sampling were scheduled at birth (sampling from umbilical cord blood) and at 9 months, 2 years, 5 years, and 8 years of age for collection of data on breast-feeding patterns, vaccinations, and viral childhood diseases; for measurements of antibodies to islet cells (ICAs), insulin (IAAs), GAD (GADAs), and IA-2 (IA-2As); and for HLA class II typing. From 1989 until the time of analysis (1999), 1,002 of 1,553 offspring recruited at birth had reached the age of 2 years; 823 (82%) participated in the 2-year follow-up visit and were included into this analysis (568 from a mother, 228 from a father, and 27 from both parents with type 1 diabetes). OBJECTIVE -Environmental factors have been suggested to play an important role in the pathogenesis of type 1 diabetes. The aim of this study was to assess the influence of breast-feeding, vaccinations, and childhood viral diseases on the initiation of islet autoimmunity in early childhood.
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(median follow-up time from birth to last contact or diabetes onset of the total population 3.1 years, range 1.3-9.0). The 179 families (18%) lost to follow-up either had refused participation in the 2-year visit or had moved to an unknown address. A total of 31 (3.8%) offspring developed antibodies to one or more islet autoantigens by the age of 2 years, and 10 (all with islet antibodies) developed type 1 diabetes by the time of follow-up (median onset age 3.3 years, range 1.3-8.5). HLA typing was obtained from 738 of the 823 offspring (8) . Of these, 87 offspring had t h e H L A g e n o t y p e D R B 1 * 0 3 / 0 4 (DQB1*57non-Asp) or DRB1*04/04 (DQB1*57non-Asp). Of these 87 genetically "high-risk" subjects, 13 (14.9%) developed islet antibodies by the age of 2 years.
Exposure assessment
Data on breast-feeding, vaccinations, and infections were collected by structured questionnaires (available from the authors on request), which were distributed to the families at birth and at 9 months, 2 years, 5 years, and 8 years of age. Questionnaires were completed by the families and returned by mail with vaccination records. Once the questionnaires were returned, families were contacted by phone to ascertain correctness of the completed questionnaires. The following variables were recorded and analyzed:
• The duration of overall (total) breastfeeding (defined as the period when the child received maternal breast milk, regardless of other food supplements) and exclusive breast-feeding (defined as the period when the child received no food other than breast milk)
• Antibody assays and HLA determination IAAs, GADAs, IA-2As, and ICAs were analyzed as previously described (6, 7, 9) . Antibody positivity was defined by the 99th percentile of antibody levels in nondiabetic control children (7, 9) . HLA-DR and -DQ alleles were determined using polymerase chain reaction-amplified DNA and nonradioactive sequence-specific oligonucleotide probes (10).
Outcome variables
The major outcome variable was the presence (antibody-positive group) or absence (antibody-negative group) of islet antibodies in the 2-year sample. Presence of islet antibody was defined as having at least 1 islet antibody above the 99th percentile of control samples confirmed by repeated measurements (6) . Presence of IAA was defined as being positive in the protein A/G-IAA assay (9) .
Statistical analysis
The analyses of breast-feeding duration were performed separately for offspring from mothers and fathers with type 1 diabetes. If both parents had diabetes, offspring were included in the mother cohort. The breastfeeding times of islet antibody-positive and -negative offspring were compared with the Mann-Whitney U test and Kaplan-Meier life-table analysis. The number of islet antibody-positive and -negative offspring who were breast-fed Ͼ3 months were compared with Fisher' s exact test. The number of islet antibody-positive and -negative offspring receiving specific vaccinations were compared by 2 analysis or Fisher' s exact test. Offspring who had developed islet antibodies or diabetes before the first immunization with a specific vaccination were excluded from the analysis of that respective vaccine. Odds ratios were calculated as the ratio of the proportion of offspring with islet antibodies in those with breast-feeding times greater and less than 3 months and in those with and without a vaccination event. Statistical methods were performed using version 8.0.1 of the Statistical Package for Social Sciences (SPSS, Chicago).
RESULTS
Breast-feeding
The proportion of offspring who were breast-fed (73%) and the duration of total (median 12 weeks) or exclusive (median 4 weeks) breast-feeding were significantly lower in offspring from mothers with type 1 diabetes compared with offspring from fathers with type 1 diabetes (85% proportion, 16 weeks of total breast-feeding, 11 weeks of exclusive breast-feeding; P Ͻ 0.0001). In offspring from mothers with diabetes, there were no significant differences in breast-feeding times between islet antibody-positive (median total 16 weeks, exclusive 8 weeks) and islet antibody-negative children (median total 12 weeks, exclusive 4 weeks) by Mann-Whitney U comparison or by life-table analysis ( Fig.  1A and C) . Of islet antibody-positive offspring, 28.6% compared with 41.5% of islet antibody-negative offspring received supplement feeding from birth ( Fig. 1C) (P = 0.33). Separate analysis in HLA highrisk offspring also showed no differences in breast-feeding patterns between islet antibody-positive and -negative offspring (data not shown). In offspring from fathers with diabetes, a non-statistically significant reduction in exclusive and total breastfeeding times was observed in the islet antibody-positive cohort compared with the islet antibody-negative offspring (median total 10 vs. 16 weeks, P = 0.41; median exclusive 4 vs. 12 weeks, P = 0.31), and 44% of islet antibody-positive offspring and 25% of islet antibody-negative offspring from fathers with diabetes received supplement feeding from the time of birth (Fig. 1D ) (P = 0.36). Previous studies examined diabetes risk with respect to a breast-feeding time of greater or less than 3 months. The relative risks of developing islet antibodies in the BABYDIAB offspring were 1.25 (95% CI 0.5-3.0) and 1.45 (0.6-3.3) for exclusive and total breastfeeding durations Ͼ3 months in offspring from diabetic mothers. In offspring from fathers, the relative risks were 0.65 for both exclusive and total durations (95% CI 0.2-2.5 and 0.2-2.2, respectively) (Fig. 2) . All 10 children who developed diabetes were breast-fed, and 5 had a total breastfeeding time Ͼ3 months (Table 1) .
Vaccinations and viral disease No significant differences in the prevalence of BCG, DTP, HIB, polio, TBE, or MMR vaccinations were found between islet antibody-positive and -negative offspring. BCG vaccination was performed in 109 (16.6%) of 658 offspring, including 6
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Figure 2-Risk (odds ratio) for developing islet antibodies with respect to environmental factors. Relative risks (᭹) are shown with their 95% CI. None of the shown factors had a significant influence on the development of islet antibodies.
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(19.4%) of 31 with islet antibodies. Onethird of islet antibody-positive offspring from diabetic fathers and 3 of the 10 offspring who developed diabetes were vaccinated with the BCG vaccine ( Table 1 ). All 3 vaccinated progressors developed diabetes before 4 years of age. Almost all of the offspring received tetanus, diphtheria, and polio vaccines, and the majority also received pertussis vaccines. The frequency of vaccination in offspring with islet antibodies was 100% for tetanus, 100% for diptheria, 100% for polio, and 90.3% for pertussis. In offspring without islet antibodies, the frequency of vaccination was 99.5% for tetanus, 99.6% for diptheria, 98.7% for polio, and 90.7% for pertussis. HIB vaccination was performed in 48% of the offspring with islet antibodies, compared with 42% of the offspring without islet antibodies, and in 6 (60%) offspring who developed diabetes (Table 1) . TBE vaccination was infrequent (7.6%), but none of the offspring who developed islet antibodies or diabetes were vaccinated before the appearance of islet autoimmunity ( Environmental factors and islet autoimmunity 
*B, both parents with diabetes; F, father with diabetes; M, mother with diabetes. ᭹, Yes; ᭺, no. †Received vaccination after development of first antibody.
mothers were breast-fed less than offspring of diabetic fathers. In offspring from mothers with diabetes, duration of exclusive and total breast-feeding did not differ between islet antibody-positive and -negative children, and breast-feeding of 3 months or longer was not associated with protection from islet antibody or diabetes development. Also, no differences were observed when offspring with HLA high-risk genotypes were analyzed separately. The results of this study, which is the largest study of prospectively followed children of parents with type 1 diabetes, are concordant with a report from the U.S., in which no association between duration of breast-feeding and islet autoimmunity in 18 first-degree relatives who developed islet antibodies in childhood was found (11), and with a study from Australia (12), in which the relationship of breast-feeding and the introduction of cow' s milk formula to islet antibody positivity in 322 children of diabetic parents was prospectively determined. Moreover, life-tables between the antibodypositive and -negative cohorts were rather indicative of a longer breast-feeding time in the antibody-positive group. Thus, it is unlikely that a significant major protective effect could be seen with higher numbers. These results indicate that breast-feeding or early introduction of cow' s milk are unlikely to be major factors that determine islet autoimmunity in offspring from mothers with type 1 diabetes. Moreover, they suggest that mothers with type 1 diabetes cannot protect their children from autoimmunity by long exposure to breast milk. In offspring born to a diabetic father and breast-fed from a nondiabetic mother, we observed a slight but not statistically significant reduction in both exclusive and total breast-feeding times in the islet antibody-positive cohort. Therefore, we cannot exclude the possibility that a positive influence of breast-feeding will be revealed when higher numbers of offspring from fathers with type 1 diabetes have been recruited and followed. A tendency toward protection would be consistent with data available from the general population, in which lack of breast-feeding or short duration of breast-feeding is associated with an increased incidence of type 1 diabetes (2). The difference observed between offspring from mothers with type 1 diabetes compared with those from fathers with type 1 diabetes underscores the importance of performing separate analyses of risk associated with breast-feeding patterns.
Vaccinations also represent early exposure to the environment. None of the vaccinations studied (BCG, HIB, DTP, polio, TBE, and MMR) were found to be associated with the development of islet-associated antibodies. In particular, BCG vaccination has been suggested to have a protective effect on the development of type 1 diabetes in humans (13) . Our results do not support a protective role of BCG immunization on the development of islet autoimmunity. In contrast, they show that the proportion of offspring who developed autoimmunity and early childhood diabetes after receiving BCG vaccination was relatively high. MMR vaccination has also been suggested to influence diabetes development. Even as a study from Finland observed a halt of the steadily increasing diabetes incidence rate after the introduction of MMR vaccination (4), a report from Germany found that 7 children developed type 1 diabetes shortly after receiving active mumps/measles vaccination (5). In our study, antibodies neither appeared more often after MMR vaccination nor were found more often in vaccinated children compared with offspring that were not MMR vaccinated. Also, no influence by vaccination on the development of islet autoimmunity was found in a cohort of first-degree relatives from the U.S. (14) . Overall, the findings in first-degree relatives are consistent with a report from New Zealand that found no associations between year-by-year incidences of childhood diabetes and the introduction, alteration, or abandonment of vaccination programs (15) .
In summary, we showed that breastfeeding and vaccination programs had no significant association with the development of islet autoimmunity during early childhood in offspring from parents with type 1 diabetes. Therefore, we suggest that these environmental factors are unlikely to have a major causal influence on initiating islet autoimmunity in such genetically susceptible children.
